Jove
Visualize
Contact Us

Related Experiment Videos

Alejo Corrales1, Andrea Abadi2, Gastón Bartoli3

  • 1Magíster en Biología Molecular e Ingeniería Genética, Universidad Favaloro. Docente de la Universidad Nacional de Tucumán (UNT). Presidente del Capítulo de Psiquiatría Genética, Asociación Argentina de Psiquiatras (AAP), Buenos Aires, Argentina.. alejocorrales@hotmail.com.

Vertex (Buenos Aires, Argentina)
|April 11, 2026
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probiotics in reducing negative symptoms of schizophrenia: A systematic review and meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

TOXTRUST: a tool leveraging the Dempster-Shafer Theory for robust integration of NAM results in decision-making considering uncertainty.

NAM journal·2026
Same author

Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus Report.

Bipolar disorders·2026
Same author

Prevalence, Severity and Correlates of Post-traumatic Stress Disorder in 205 Outpatients with Schizophrenia: Results from a Cross-sectional, Observational Study Assessing Diagnoses via the Mini-International Neuropsychiatric Interview.

CNS spectrums·2026
Same author

Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis.

Psychiatry research·2026
Same author

Real-World Data From a Group Parent Management Training Program Enhanced Using Artificial Intelligence: Qualitative Study.

JMIR formative research·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Summary
This summary is machine-generated.

This consensus synthesizes current evidence on adult schizophrenia treatment, covering pharmacological and psychosocial strategies. It provides updated recommendations for comprehensive, person-centered care, including managing acute exacerbations and long-term maintenance.

Area of Science:

  • Psychiatry
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • Schizophrenia requires ongoing, evidence-based therapeutic management.
  • Previous consensus parts established the methodological framework.
  • Adult schizophrenia treatment necessitates updated, comprehensive strategies.

Purpose of the Study:

  • To synthesize current scientific evidence on therapeutic approaches for adult schizophrenia.
  • To provide updated recommendations for the comprehensive management of schizophrenia in adults.
  • To guide clinicians in optimizing treatment strategies for schizophrenia.

Main Methods:

  • Multidisciplinary expert panel review.
  • Exhaustive and systematic literature review.

Related Experiment Videos

  • Structured discussion and consensus-building process.
  • Main Results:

    • Recommendations cover pre-prescription considerations, acute exacerbation management, and first/second-line pharmacotherapy.
    • Detailed analysis of clozapine, long-acting injectables (LAI), antipsychotic switching, augmentation, and combination therapies.
    • Evidence on complementary therapies (ECT, rTMS), adherence, response/remission/recovery, relapse prevention, maintenance, comorbidities, pseudoresistance, and psychosocial interventions.

    Conclusions:

    • An integral, longitudinal, and person-centered approach is essential for schizophrenia management.
    • Updated evidence supports diverse pharmacological and psychosocial interventions.
    • The consensus provides a framework for optimizing adult schizophrenia care.